KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Raw Materials (2017 - 2025)

Historic Raw Materials for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $6.1 million.

  • Bionano Genomics' Raw Materials rose 6892.53% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year increase of 6892.53%. This contributed to the annual value of $6.7 million for FY2024, which is 1125.94% down from last year.
  • Latest data reveals that Bionano Genomics reported Raw Materials of $6.1 million as of Q3 2025, which was up 6892.53% from $6.4 million recorded in Q2 2025.
  • Over the past 5 years, Bionano Genomics' Raw Materials peaked at $8.9 million during Q2 2024, and registered a low of $837000.0 during Q2 2022.
  • For the 5-year period, Bionano Genomics' Raw Materials averaged around $5.0 million, with its median value being $5.8 million (2023).
  • As far as peak fluctuations go, Bionano Genomics' Raw Materials tumbled by 6094.58% in 2021, and later skyrocketed by 64121.86% in 2023.
  • Over the past 5 years, Bionano Genomics' Raw Materials (Quarter) stood at $4.6 million in 2021, then rose by 14.41% to $5.3 million in 2022, then surged by 42.26% to $7.6 million in 2023, then decreased by 11.26% to $6.7 million in 2024, then decreased by 9.41% to $6.1 million in 2025.
  • Its Raw Materials was $6.1 million in Q3 2025, compared to $6.4 million in Q2 2025 and $6.6 million in Q1 2025.